REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,399 | -54.7% | 11,979 | 0.0% | 0.02% | -47.5% |
| Q2 2023 | $303,188 | -22.7% | 11,979 | -1.6% | 0.04% | -23.1% |
| Q1 2023 | $392,286 | +59.6% | 12,179 | -8.5% | 0.05% | +57.6% |
| Q4 2022 | $245,740 | -31.5% | 13,312 | 0.0% | 0.03% | -36.5% |
| Q3 2022 | $359,000 | +95.1% | 13,312 | 0.0% | 0.05% | +108.0% |
| Q2 2022 | $184,000 | -29.2% | 13,312 | 0.0% | 0.02% | -19.4% |
| Q1 2022 | $260,000 | +19.8% | 13,312 | 0.0% | 0.03% | +29.2% |
| Q4 2021 | $217,000 | -41.5% | 13,312 | 0.0% | 0.02% | -35.1% |
| Q3 2021 | $371,000 | -6.1% | 13,312 | 0.0% | 0.04% | -15.9% |
| Q2 2021 | $395,000 | +6.2% | 13,312 | 0.0% | 0.04% | +4.8% |
| Q1 2021 | $372,000 | -1.3% | 13,312 | 0.0% | 0.04% | -23.6% |
| Q4 2020 | $377,000 | +12.5% | 13,312 | 0.0% | 0.06% | +27.9% |
| Q3 2020 | $335,000 | -4.0% | 13,312 | 0.0% | 0.04% | +104.8% |
| Q2 2020 | $349,000 | +109.0% | 13,312 | +17.7% | 0.02% | -16.0% |
| Q1 2020 | $167,000 | +3.1% | 11,312 | +13.1% | 0.02% | +13.6% |
| Q4 2019 | $162,000 | +3.8% | 10,004 | -16.7% | 0.02% | +4.8% |
| Q3 2019 | $156,000 | +20.0% | 12,004 | +20.0% | 0.02% | +10.5% |
| Q2 2019 | $130,000 | -17.7% | 10,004 | 0.0% | 0.02% | -17.4% |
| Q1 2019 | $158,000 | -43.8% | 10,004 | -11.6% | 0.02% | -46.5% |
| Q4 2018 | $281,000 | 0.0% | 11,312 | 0.0% | 0.04% | 0.0% |
| Q3 2018 | $281,000 | -19.3% | 11,312 | 0.0% | 0.04% | -21.8% |
| Q2 2018 | $348,000 | 0.0% | 11,312 | 0.0% | 0.06% | -8.3% |
| Q1 2018 | $348,000 | -13.9% | 11,312 | 0.0% | 0.06% | +9.1% |
| Q4 2017 | $404,000 | +29.5% | 11,312 | 0.0% | 0.06% | +25.0% |
| Q3 2017 | $312,000 | -11.1% | 11,312 | -15.0% | 0.04% | -15.4% |
| Q2 2017 | $351,000 | +26.7% | 13,312 | 0.0% | 0.05% | +20.9% |
| Q1 2017 | $277,000 | +0.4% | 13,312 | 0.0% | 0.04% | -8.5% |
| Q4 2016 | $276,000 | +27.8% | 13,312 | 0.0% | 0.05% | +23.7% |
| Q3 2016 | $216,000 | -2.7% | 13,312 | -18.4% | 0.04% | -7.3% |
| Q2 2016 | $222,000 | -64.5% | 16,312 | -11.0% | 0.04% | -64.7% |
| Q1 2016 | $626,000 | 0.0% | 18,328 | 0.0% | 0.12% | 0.0% |
| Q4 2015 | $626,000 | +14.9% | 18,328 | 0.0% | 0.12% | +17.2% |
| Q3 2015 | $545,000 | -7.0% | 18,328 | 0.0% | 0.10% | +3.1% |
| Q2 2015 | $586,000 | +50.6% | 18,328 | -2.3% | 0.10% | +50.0% |
| Q1 2015 | $389,000 | -0.3% | 18,764 | -18.5% | 0.06% | -35.4% |
| Q4 2014 | $390,000 | – | 23,018 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |